Sentinel lymph node biopsy for staging early breast cancer: Minimizing the trade-off by maximizing the accuracy

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 973-975

  Gadd, Michele ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; EDITORIAL; FALSE NEGATIVE RESULT; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MASTECTOMY; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 66149090749     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp306     Document Type: Editorial

References (21)

1. Krag D, Anderson S, Julian TB et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8(10): 881-888.
2. Cox C, White L, Allred N et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 2006; 13(5): 708-711.
3. Naik AM, Fey J, Gemignani M et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. A follow-up study of 4008 procedures. Ann Surg 2004; 240: 462-471.
4. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
5. Canavese G, Catturich A, Vecchio C et al. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: Results of randomized trial. Ann Oncol 2009; 20: 1001-1007.
6. Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumorpositive sentinel node: Implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001; 20: 230-237.
7. Galimberti V. International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol 2006; 24: 210-211.
8. Nano MT, Kollias J, Farshid G et al. Clinical impact of false-negative sentinel node biopsy in primary breast cancer. Br J Surg 2002; 89(11): 1430-1434.
9. Cady B, Stone M, Schuler J et al. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301-308.
10. Haffty BG, Ward B, Pathare P et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 1997; 15: 691-700.
11. Asad J, Jacobson A, Estabrook A et al. Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? Am J Surg 2008; 196(4): 527-529.
12. Moffat F, Senofsky GM, Davis K et al. Axillary node dissection for early stage breast cancer: Some is good, but all is better. J Surg Oncol 2006; 51: 8-13.
13. Fisher B, Montague E, Redmond C et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial. Cancer 1977; 39(6): 2827-2839.
14. Recht A, Pierce SM, Abner A et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinomas. J Clin Oncol 1991; 9: 988-996.
15. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. A metaanalysis. Cancer 2006; 106: 4-16.
16. Martin RCGII, Chagpar A, Scoggins CR et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005; 241(6): 1005-1015.
17. Wong SL, Edwards MJ, Chao C et al. Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192: 684-691.
18. Lyman G, Giuliano A, Somerfield M et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph-node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23(30): 7703-7720.
19. Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Nat Can Inst 2006; 98(9): 599-609.
20. Crane-Okada R, Wascher R, Elashoff D et al. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 2008; 15(7): 1996-2005.
21. Purushotham AD, Upponi S, Klevesath MB et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Result from a randomized controlled trial. J Clin Oncol 2005; 23: 4312-4321.